This document discusses strategies to improve stroke care and treatment. It outlines the benefits of stroke unit care compared to general medical wards, including reduced mortality, dependency, and length of stay. It also discusses various quality indicators that stroke units and centers should monitor, such as thrombolysis rates and door-to-needle times. The document advocates for a tiered system of stroke care with certified acute stroke units and centers that can provide more advanced treatments and meet quality standards. It also discusses strategies to optimize pre-hospital management and in-hospital workflows to increase thrombolysis treatment rates and reduce treatment delays.
Mechanical thrombectomy with stent retrieverDr Vipul Gupta
Vipul Gupta discusses balloon assisted coiling in ruptured cerebral aneurysms and mechanical thrombectomy with stent retrievers. He summarizes several key randomized controlled trials that demonstrated the benefits of endovascular therapy using stent retrievers over standard medical therapy alone for acute ischemic stroke. The trials showed significant improvements in revascularization, clinical outcomes, and mortality. The 2015 AHA/ASA guidelines recommend endovascular therapy with stent retrievers for select patients within 6 hours of stroke onset based on the evidence from these trials. The document also reviews techniques for mechanical thrombectomy and strategies to optimize outcomes.
This document summarizes evidence from multiple clinical trials evaluating the use of thrombolysis/tissue plasminogen activator (tPA) for acute ischemic stroke. It discusses trials showing small benefits for functional outcomes with tPA if given within 3 hours, as well as increased risks of intracranial hemorrhage. Later trials found no clear benefits for tPA between 3-6 hours. Overall, tPA for acute stroke provides only modest benefits for a small proportion of patients, but is also associated with significant risks.
This document discusses heart transplantation and mechanical circulatory support (MCS) as treatments for end-stage heart disease. It provides the following key points:
1) Heart transplantation is currently the only long-term solution for managing end-stage heart disease, as it allows patients to resume a normal lifestyle.
2) Survival rates for heart transplant patients have improved significantly with advances in immunosuppression and care.
3) While MCS is an evolving technology, it does not provide a long-term solution, devices have limited durability, and patients face substantial morbidity and reduced quality of life compared to transplant recipients.
4) Studies are exploring inducing immune tolerance through chimerism to eliminate the need for
Post-traumatic epilepsy (PTE) is defined as recurrent seizures occurring after traumatic brain injury (TBI). TBI accounts for 10-20% of epilepsy cases. Risk factors for early PTE include GCS <10, intracranial hematoma, and seizures within 24 hours of injury. Risk factors for late PTE include penetrating injury, intracranial hematoma, early PTE, and age over 35. Temporal lobes are the most common localization. Standard anticonvulsants are used to treat established PTE but prophylaxis is ineffective at preventing late PTE. Surgery may be considered for refractory late PTE if the seizure focus is well-localized.
Recent Advances In Thrombolysis In Stroke PatientAdamya Gupta
1) Recent advances in thrombolysis for stroke patients include extending the treatment window for intravenous rt-PA from 3 hours to 4.5 hours post-stroke onset based on the ECASS III trial results.
2) Intravenous rt-PA is still the standard of care for eligible patients within 4.5 hours, but endovascular thrombectomy is now recommended for eligible patients with a large vessel occlusion up to 24 hours from last known normal.
3) Treatment protocols now focus on a rapid door-to-needle time of 60 minutes or less for intravenous rt-PA and include advances in imaging such as CTA and perfusion imaging to identify patients that may benefit from endovascular thrombectomy.
This document summarizes guidelines and evidence for assessing low-risk chest pain patients. It discusses how clinical history, examination, ECG, and troponin levels can be used to predict risk of acute coronary syndrome. The HEART score and TIMI score are presented as useful tools, with the HEART score shown to more accurately stratify low-risk patients. For those deemed low-risk with a HEART score of 0-3 and negative troponins, the risk of adverse events within 30 days is approximately 1.6%. Studies exploring shared decision making and accelerated diagnostic protocols have achieved even lower risks of around 0.8%. Pre-test probability of coronary artery disease should also be considered to guide need for further
The document discusses the evolution of treatments for acute ischemic stroke (AIS), including intravenous thrombolysis and mechanical thrombectomy. It summarizes key randomized trials that established the benefits of mechanical thrombectomy. The first-generation trials using early thrombectomy devices did not show benefit, but recent trials using stent retrievers demonstrated significantly improved recanalization rates and superior outcomes for mechanical thrombectomy combined with intravenous thrombolysis compared to intravenous thrombolysis alone in eligible patients presenting within 6 hours of stroke onset. The document concludes that mechanical thrombectomy is now a standard treatment for AIS but remains underutilized.
Mechanical thrombectomy in acute stroke [Autosaved].pptxNeurologyKota
1. The document discusses various techniques for mechanical thrombectomy in acute stroke, including thrombectomy devices, thromboaspiration, and thrombolysis.
2. It summarizes key trials investigating mechanical thrombectomy including DAWN, DEFUSE 3, and a basilar artery occlusion trial. The DAWN and DEFUSE 3 trials showed improved outcomes with thrombectomy plus standard care compared to standard care alone for certain patients.
3. The document outlines considerations for implementing a mechanical thrombectomy program, including patient selection criteria, imaging guidance, procedural timelines, equipment needs, and cost estimates.
Mechanical thrombectomy with stent retrieverDr Vipul Gupta
Vipul Gupta discusses balloon assisted coiling in ruptured cerebral aneurysms and mechanical thrombectomy with stent retrievers. He summarizes several key randomized controlled trials that demonstrated the benefits of endovascular therapy using stent retrievers over standard medical therapy alone for acute ischemic stroke. The trials showed significant improvements in revascularization, clinical outcomes, and mortality. The 2015 AHA/ASA guidelines recommend endovascular therapy with stent retrievers for select patients within 6 hours of stroke onset based on the evidence from these trials. The document also reviews techniques for mechanical thrombectomy and strategies to optimize outcomes.
This document summarizes evidence from multiple clinical trials evaluating the use of thrombolysis/tissue plasminogen activator (tPA) for acute ischemic stroke. It discusses trials showing small benefits for functional outcomes with tPA if given within 3 hours, as well as increased risks of intracranial hemorrhage. Later trials found no clear benefits for tPA between 3-6 hours. Overall, tPA for acute stroke provides only modest benefits for a small proportion of patients, but is also associated with significant risks.
This document discusses heart transplantation and mechanical circulatory support (MCS) as treatments for end-stage heart disease. It provides the following key points:
1) Heart transplantation is currently the only long-term solution for managing end-stage heart disease, as it allows patients to resume a normal lifestyle.
2) Survival rates for heart transplant patients have improved significantly with advances in immunosuppression and care.
3) While MCS is an evolving technology, it does not provide a long-term solution, devices have limited durability, and patients face substantial morbidity and reduced quality of life compared to transplant recipients.
4) Studies are exploring inducing immune tolerance through chimerism to eliminate the need for
Post-traumatic epilepsy (PTE) is defined as recurrent seizures occurring after traumatic brain injury (TBI). TBI accounts for 10-20% of epilepsy cases. Risk factors for early PTE include GCS <10, intracranial hematoma, and seizures within 24 hours of injury. Risk factors for late PTE include penetrating injury, intracranial hematoma, early PTE, and age over 35. Temporal lobes are the most common localization. Standard anticonvulsants are used to treat established PTE but prophylaxis is ineffective at preventing late PTE. Surgery may be considered for refractory late PTE if the seizure focus is well-localized.
Recent Advances In Thrombolysis In Stroke PatientAdamya Gupta
1) Recent advances in thrombolysis for stroke patients include extending the treatment window for intravenous rt-PA from 3 hours to 4.5 hours post-stroke onset based on the ECASS III trial results.
2) Intravenous rt-PA is still the standard of care for eligible patients within 4.5 hours, but endovascular thrombectomy is now recommended for eligible patients with a large vessel occlusion up to 24 hours from last known normal.
3) Treatment protocols now focus on a rapid door-to-needle time of 60 minutes or less for intravenous rt-PA and include advances in imaging such as CTA and perfusion imaging to identify patients that may benefit from endovascular thrombectomy.
This document summarizes guidelines and evidence for assessing low-risk chest pain patients. It discusses how clinical history, examination, ECG, and troponin levels can be used to predict risk of acute coronary syndrome. The HEART score and TIMI score are presented as useful tools, with the HEART score shown to more accurately stratify low-risk patients. For those deemed low-risk with a HEART score of 0-3 and negative troponins, the risk of adverse events within 30 days is approximately 1.6%. Studies exploring shared decision making and accelerated diagnostic protocols have achieved even lower risks of around 0.8%. Pre-test probability of coronary artery disease should also be considered to guide need for further
The document discusses the evolution of treatments for acute ischemic stroke (AIS), including intravenous thrombolysis and mechanical thrombectomy. It summarizes key randomized trials that established the benefits of mechanical thrombectomy. The first-generation trials using early thrombectomy devices did not show benefit, but recent trials using stent retrievers demonstrated significantly improved recanalization rates and superior outcomes for mechanical thrombectomy combined with intravenous thrombolysis compared to intravenous thrombolysis alone in eligible patients presenting within 6 hours of stroke onset. The document concludes that mechanical thrombectomy is now a standard treatment for AIS but remains underutilized.
Mechanical thrombectomy in acute stroke [Autosaved].pptxNeurologyKota
1. The document discusses various techniques for mechanical thrombectomy in acute stroke, including thrombectomy devices, thromboaspiration, and thrombolysis.
2. It summarizes key trials investigating mechanical thrombectomy including DAWN, DEFUSE 3, and a basilar artery occlusion trial. The DAWN and DEFUSE 3 trials showed improved outcomes with thrombectomy plus standard care compared to standard care alone for certain patients.
3. The document outlines considerations for implementing a mechanical thrombectomy program, including patient selection criteria, imaging guidance, procedural timelines, equipment needs, and cost estimates.
Ventricular assist devices (VADs) are mechanical pumps that help the failing heart pump blood. They can be used as a bridge to transplantation, destination therapy for those not eligible for transplant, or as a bridge to recovery or decision. VADs range from short-term percutaneous devices to long-term implantable devices. Long-term devices include pulsatile flow, axial continuous flow, and total artificial hearts. Selection depends on duration of support needed, whether right or left ventricular support is required, and the patient's prognosis and treatment goals. Implantation requires open-heart surgery and postoperative management focuses on prevention of complications like bleeding, infection, and thromboembolism.
1. Successful PCI of chronic total occlusions (CTO) is associated with improved symptoms, increased exercise capacity, reduced need for CABG, and survival benefit compared to failed CTO PCI based on observational studies.
2. Randomized trials are still needed to provide high-level evidence on the benefits of CTO PCI given limitations of observational data though several large randomized trials are underway.
3. Expert operators can now achieve high success rates of over 90% for CTO PCI with low complication rates even for complex CTOs, using bilateral injections, IVUS, retrograde approaches and specialized guidewires and catheters.
1) The CLOSURE-I trial found that percutaneous closure of a patent foramen ovale (PFO) with the STARFlex device plus medical therapy did not provide a significant benefit over medical therapy alone in preventing recurrent stroke or transient ischemic attack in patients under age 60 who had a cryptogenic stroke or TIA and a PFO.
2) The trial observed a higher rate of atrial fibrillation and major vascular complications in the device closure group compared to medical therapy alone.
3) The results were inconclusive as to whether PFO closure benefits patient subgroups based on the degree of shunting or presence of an atrial septal aneurysm.
Guidelines in the management of carotid stenosisuvcd
This document provides an overview of guidelines for the management of carotid stenosis. It discusses:
1) Stroke is a major cause of death, with many caused by carotid artery disease. The risk of stroke is directly related to the degree of stenosis.
2) Natural history studies show that the risk of stroke is highest in the first year after symptoms and then declines over time. The risk is higher for more severe stenosis.
3) Early trials demonstrated the benefits of carotid endarterectomy (CEA) in reducing stroke risks compared to medical management alone for symptomatic and some asymptomatic patients.
4) Later trials evaluated carotid angioplasty and stenting (CAS) as an alternative to CEA but
This document discusses the current management of cardiogenic shock. It defines cardiogenic shock and describes its causes, predictors of mortality, and pathophysiology. Treatment involves hemodynamic support, volume management, inotropic drugs, and early revascularization, which significantly reduces mortality. Mechanical circulatory support devices like IABP, Tandem Heart, Impella, and ECMO can further improve hemodynamics and outcomes when used as adjuncts to optimal medical therapy. Timing of revascularization is critical, with survival benefits seen for up to 48 hours after myocardial infarction onset. Special considerations are discussed for managing shock in the elderly, from mechanical causes, and with specific device therapies.
EMGuideWire's Radiology Reading Room: Aortic DissectionSean M. Fox
The Department of Emergency Medicine at Carolinas Medical Center is passionate about education! Dr. Michael Gibbs is a world-renowned clinician and educator and has helped guide numerous young clinicians on the long path of Mastery of Emergency Medical Care. With his oversight, the EMGuideWire team aim to help augment our understanding of emergent imaging. You can follow along with the EMGuideWire.com team as they post these educational, self-guided radiology slides or you can also use this section to learn more in-depth about specific conditions and diseases. This Radiology Reading Room pertains to Aortic Dissection and is brought to you by Matthew Cravens, MD, Tyler Siekmann, MD, and Shelby Hixson, PA. It is has special guest editor: Bryant Allen, MD
This document discusses carotid artery stenting (CAS) as an alternative to carotid endarterectomy (CEA) for treatment of carotid artery stenosis. It provides details on patient selection criteria and describes the CAS procedure, including diagnostic arteriography, embolic protection device placement, stent placement, and post-procedure care. Several major clinical trials are summarized that demonstrated CAS to be non-inferior to CEA for reducing risk of stroke in both symptomatic and asymptomatic patients.
This document describes equipment, catheters, and basic intervals used in electrophysiology (EP) studies. It discusses radiographic tables, EP equipment like cardiac stimulators and mapping/ablation catheters. Patient preparation includes fasting, IV access, monitoring equipment. EP catheters come in different sizes and have electrodes for recording electrical activity. Basic intervals measured include P wave to atrial interval, atrial-His bundle interval, His-ventricular interval, and sinus node recovery time. Drive train stimulation with single, double, or triple extra stimuli is used. The document continues with further discussions of EP protocols, arrhythmias, ablation, and pre-excitation pathways.
This document provides an overview of cardiac resynchronization therapy (CRT). It discusses how conduction delays can lead to electromechanical dyssynchrony and impair the heart's function. CRT aims to improve this synchrony and thereby improve systolic and diastolic function. The document outlines different types of dyssynchrony and methods to assess it, including echocardiography. Current guidelines recommend CRT for symptomatic heart failure patients with low ejection fraction and wide QRS duration. The implantation procedure involves placing right atrial/ventricular leads and a left ventricular lead via the coronary sinus.
This document outlines a stroke management protocol to standardize and expedite treatment for acute ischemic stroke patients. It discusses the importance of minimizing delays from symptom onset to treatment administration given the time-sensitive nature of stroke. The protocol details steps in the pre-hospital, emergency department, and in-hospital phases including rapid neurological assessment, imaging, criteria evaluation, and intravenous thrombolysis administration if eligible, with a goal of completing the entire process within 60 minutes or less. Adhering closely to established guidelines and protocols is emphasized to optimize outcomes for stroke patients.
Acute management of patients with stroke is to stabilize the patient and to complete initial evaluation and assessment, including imaging and laboratory studies, within 60 minutes of patient arrival.
Critical decisions focus on the need for intubation, blood pressure control, and determination of risk/benefit for thrombolytic intervention.
ECMO CPR
ECMO in Cardiac arrest has increased exponentially in the past 10 years, on the back of, up until very recently, non-randomised, predominantly retrospective studies.
What is the efficacy?
Appropriate patient selection?
Cost effectiveness and model of delivery of ECPR?
Finally is ECMO really the intervention or just optimising the chain of survival?
This document provides an overview of mechanical circulatory support devices. It discusses the evolution of such devices and their terminology. Temporary devices discussed include intra-aortic balloon pumps and Impella pumps. Long-term devices discussed include pulsatile flow devices like HeartMate I as well as continuous flow devices like HeartMate II, HeartWare HVAD, and HeartMate 3. Clinical trials are summarized that evaluated these devices as bridges to transplant or destination therapy. Biventricular support devices like the total artificial heart are also covered. The document concludes with recommendations from organizations on the use of these devices.
Non invasive evaluation of arrhythmias Sunil Reddy D
Event monitors are used to monitor cardiac rhythms intermittently over periods of 14 to 30 days. There are two main types - loop event recorders that continuously record data when activated, and post-event monitors that are applied after symptoms occur. Real-time cardiac monitors provide continuous monitoring for up to 30 days and automatically transmit data to monitoring stations. The optimal monitoring method depends on symptom frequency and suspicion of life-threatening arrhythmias. Exercise testing can help provoke and evaluate arrhythmias but has limited utility for syncope. Monitoring asymptomatic rhythms is important for conditions like atrial fibrillation.
This document provides an overview of sinus of Valsalva aneurysm (SOVA). Key points include:
- SOVA is a thin-walled bulge that originates from the aortic sinuses, most commonly the right sinus. It can rupture into the right heart chambers.
- Presentation depends on rupture status - ruptured SOVA causes a continuous murmur while unruptured can cause arrhythmias or embolism. Imaging helps confirm diagnosis.
- Surgery is the standard treatment, involving a median sternotomy, cardiopulmonary bypass, and patch closure of the defect from inside the aorta and heart chambers. Device closure is also possible. Outcomes are generally good but
This document discusses indications and techniques for carotid artery stenting (CAS). It notes that symptomatic stenosis over 70% on non-invasive imaging or over 50% on catheter angiography are indications for revascularization. Asymptomatic stenosis over 70% may also be treated if life expectancy is over 5 years and stenosis is over 80%. The technique involves pre- and post-dilation of stents with the use of protection devices to prevent embolic strokes. Results depend on the operator's experience and complications include strokes, hypotension, and restenosis. Larger trials found CAS and CEA to have similar outcomes, with CAS preferred for younger patients, though CEA is preferred in certain high risk cases.
This document discusses percutaneous mitral valve interventions for mitral regurgitation. It begins by describing the anatomy of the mitral valve and causes of mitral regurgitation. It then discusses the natural history of mitral regurgitation and indications for surgery. Current percutaneous options are described including the MitraClip device, which is the only FDA approved one. The MitraClip procedure involves grasping the leaflets edges to reduce regurgitation. Early results show high rates of procedural success for MitraClip in patients at high risk for surgery. Complications are usually low at 15-19% and include bleeding, partial clip detachment, and stroke.
http://www.theheart.org/web_slides/1425587.do
A randomized to placebo or ivabradine study on Systolic Heart Failure Treatment with the If Inhibitor Ivabradine (SHIFT) with patients on standard HF medications according to guidelines
How to manage delays in stroke treatment Jacek StaszewskiJacek Staszewski
This document discusses strategies to manage delays in stroke treatment. It notes that while thrombolysis and thrombectomy have improved outcomes, time is still critical factor. Various factors can contribute to delays including pre-hospital times, hospital workflows, and patient factors. Studies demonstrate improved outcomes with shorter onset-to-treatment and door-to-needle times. Initiatives like pre-notification, standardized protocols, telemedicine, and programs like Target: Stroke that focus on key strategies have been shown to reduce times and increase treatment rates. While challenges remain, an emphasis on collaboration, continuous quality improvement and learning from initiatives can help further reduce delays to improve patient outcomes.
This document summarizes a quality improvement project to implement a screening tool to improve thrombolytic therapy treatment for acute ischemic stroke patients. The project aimed to (1) improve door-to-needle times from 144 minutes to less than 80 minutes, (2) increase thrombolytic treatment rates from less than 5% to over 7%, (3) meet treatment guidelines for eligible patients over 85% of the time, and (4) have providers initiate the screening tool for 25% of eligible patients. The National Institute of Neurological Disorders and Stroke screening tool would be integrated into the emergency department's initial evaluation and treatment process over a 3-month pilot period.
Ventricular assist devices (VADs) are mechanical pumps that help the failing heart pump blood. They can be used as a bridge to transplantation, destination therapy for those not eligible for transplant, or as a bridge to recovery or decision. VADs range from short-term percutaneous devices to long-term implantable devices. Long-term devices include pulsatile flow, axial continuous flow, and total artificial hearts. Selection depends on duration of support needed, whether right or left ventricular support is required, and the patient's prognosis and treatment goals. Implantation requires open-heart surgery and postoperative management focuses on prevention of complications like bleeding, infection, and thromboembolism.
1. Successful PCI of chronic total occlusions (CTO) is associated with improved symptoms, increased exercise capacity, reduced need for CABG, and survival benefit compared to failed CTO PCI based on observational studies.
2. Randomized trials are still needed to provide high-level evidence on the benefits of CTO PCI given limitations of observational data though several large randomized trials are underway.
3. Expert operators can now achieve high success rates of over 90% for CTO PCI with low complication rates even for complex CTOs, using bilateral injections, IVUS, retrograde approaches and specialized guidewires and catheters.
1) The CLOSURE-I trial found that percutaneous closure of a patent foramen ovale (PFO) with the STARFlex device plus medical therapy did not provide a significant benefit over medical therapy alone in preventing recurrent stroke or transient ischemic attack in patients under age 60 who had a cryptogenic stroke or TIA and a PFO.
2) The trial observed a higher rate of atrial fibrillation and major vascular complications in the device closure group compared to medical therapy alone.
3) The results were inconclusive as to whether PFO closure benefits patient subgroups based on the degree of shunting or presence of an atrial septal aneurysm.
Guidelines in the management of carotid stenosisuvcd
This document provides an overview of guidelines for the management of carotid stenosis. It discusses:
1) Stroke is a major cause of death, with many caused by carotid artery disease. The risk of stroke is directly related to the degree of stenosis.
2) Natural history studies show that the risk of stroke is highest in the first year after symptoms and then declines over time. The risk is higher for more severe stenosis.
3) Early trials demonstrated the benefits of carotid endarterectomy (CEA) in reducing stroke risks compared to medical management alone for symptomatic and some asymptomatic patients.
4) Later trials evaluated carotid angioplasty and stenting (CAS) as an alternative to CEA but
This document discusses the current management of cardiogenic shock. It defines cardiogenic shock and describes its causes, predictors of mortality, and pathophysiology. Treatment involves hemodynamic support, volume management, inotropic drugs, and early revascularization, which significantly reduces mortality. Mechanical circulatory support devices like IABP, Tandem Heart, Impella, and ECMO can further improve hemodynamics and outcomes when used as adjuncts to optimal medical therapy. Timing of revascularization is critical, with survival benefits seen for up to 48 hours after myocardial infarction onset. Special considerations are discussed for managing shock in the elderly, from mechanical causes, and with specific device therapies.
EMGuideWire's Radiology Reading Room: Aortic DissectionSean M. Fox
The Department of Emergency Medicine at Carolinas Medical Center is passionate about education! Dr. Michael Gibbs is a world-renowned clinician and educator and has helped guide numerous young clinicians on the long path of Mastery of Emergency Medical Care. With his oversight, the EMGuideWire team aim to help augment our understanding of emergent imaging. You can follow along with the EMGuideWire.com team as they post these educational, self-guided radiology slides or you can also use this section to learn more in-depth about specific conditions and diseases. This Radiology Reading Room pertains to Aortic Dissection and is brought to you by Matthew Cravens, MD, Tyler Siekmann, MD, and Shelby Hixson, PA. It is has special guest editor: Bryant Allen, MD
This document discusses carotid artery stenting (CAS) as an alternative to carotid endarterectomy (CEA) for treatment of carotid artery stenosis. It provides details on patient selection criteria and describes the CAS procedure, including diagnostic arteriography, embolic protection device placement, stent placement, and post-procedure care. Several major clinical trials are summarized that demonstrated CAS to be non-inferior to CEA for reducing risk of stroke in both symptomatic and asymptomatic patients.
This document describes equipment, catheters, and basic intervals used in electrophysiology (EP) studies. It discusses radiographic tables, EP equipment like cardiac stimulators and mapping/ablation catheters. Patient preparation includes fasting, IV access, monitoring equipment. EP catheters come in different sizes and have electrodes for recording electrical activity. Basic intervals measured include P wave to atrial interval, atrial-His bundle interval, His-ventricular interval, and sinus node recovery time. Drive train stimulation with single, double, or triple extra stimuli is used. The document continues with further discussions of EP protocols, arrhythmias, ablation, and pre-excitation pathways.
This document provides an overview of cardiac resynchronization therapy (CRT). It discusses how conduction delays can lead to electromechanical dyssynchrony and impair the heart's function. CRT aims to improve this synchrony and thereby improve systolic and diastolic function. The document outlines different types of dyssynchrony and methods to assess it, including echocardiography. Current guidelines recommend CRT for symptomatic heart failure patients with low ejection fraction and wide QRS duration. The implantation procedure involves placing right atrial/ventricular leads and a left ventricular lead via the coronary sinus.
This document outlines a stroke management protocol to standardize and expedite treatment for acute ischemic stroke patients. It discusses the importance of minimizing delays from symptom onset to treatment administration given the time-sensitive nature of stroke. The protocol details steps in the pre-hospital, emergency department, and in-hospital phases including rapid neurological assessment, imaging, criteria evaluation, and intravenous thrombolysis administration if eligible, with a goal of completing the entire process within 60 minutes or less. Adhering closely to established guidelines and protocols is emphasized to optimize outcomes for stroke patients.
Acute management of patients with stroke is to stabilize the patient and to complete initial evaluation and assessment, including imaging and laboratory studies, within 60 minutes of patient arrival.
Critical decisions focus on the need for intubation, blood pressure control, and determination of risk/benefit for thrombolytic intervention.
ECMO CPR
ECMO in Cardiac arrest has increased exponentially in the past 10 years, on the back of, up until very recently, non-randomised, predominantly retrospective studies.
What is the efficacy?
Appropriate patient selection?
Cost effectiveness and model of delivery of ECPR?
Finally is ECMO really the intervention or just optimising the chain of survival?
This document provides an overview of mechanical circulatory support devices. It discusses the evolution of such devices and their terminology. Temporary devices discussed include intra-aortic balloon pumps and Impella pumps. Long-term devices discussed include pulsatile flow devices like HeartMate I as well as continuous flow devices like HeartMate II, HeartWare HVAD, and HeartMate 3. Clinical trials are summarized that evaluated these devices as bridges to transplant or destination therapy. Biventricular support devices like the total artificial heart are also covered. The document concludes with recommendations from organizations on the use of these devices.
Non invasive evaluation of arrhythmias Sunil Reddy D
Event monitors are used to monitor cardiac rhythms intermittently over periods of 14 to 30 days. There are two main types - loop event recorders that continuously record data when activated, and post-event monitors that are applied after symptoms occur. Real-time cardiac monitors provide continuous monitoring for up to 30 days and automatically transmit data to monitoring stations. The optimal monitoring method depends on symptom frequency and suspicion of life-threatening arrhythmias. Exercise testing can help provoke and evaluate arrhythmias but has limited utility for syncope. Monitoring asymptomatic rhythms is important for conditions like atrial fibrillation.
This document provides an overview of sinus of Valsalva aneurysm (SOVA). Key points include:
- SOVA is a thin-walled bulge that originates from the aortic sinuses, most commonly the right sinus. It can rupture into the right heart chambers.
- Presentation depends on rupture status - ruptured SOVA causes a continuous murmur while unruptured can cause arrhythmias or embolism. Imaging helps confirm diagnosis.
- Surgery is the standard treatment, involving a median sternotomy, cardiopulmonary bypass, and patch closure of the defect from inside the aorta and heart chambers. Device closure is also possible. Outcomes are generally good but
This document discusses indications and techniques for carotid artery stenting (CAS). It notes that symptomatic stenosis over 70% on non-invasive imaging or over 50% on catheter angiography are indications for revascularization. Asymptomatic stenosis over 70% may also be treated if life expectancy is over 5 years and stenosis is over 80%. The technique involves pre- and post-dilation of stents with the use of protection devices to prevent embolic strokes. Results depend on the operator's experience and complications include strokes, hypotension, and restenosis. Larger trials found CAS and CEA to have similar outcomes, with CAS preferred for younger patients, though CEA is preferred in certain high risk cases.
This document discusses percutaneous mitral valve interventions for mitral regurgitation. It begins by describing the anatomy of the mitral valve and causes of mitral regurgitation. It then discusses the natural history of mitral regurgitation and indications for surgery. Current percutaneous options are described including the MitraClip device, which is the only FDA approved one. The MitraClip procedure involves grasping the leaflets edges to reduce regurgitation. Early results show high rates of procedural success for MitraClip in patients at high risk for surgery. Complications are usually low at 15-19% and include bleeding, partial clip detachment, and stroke.
http://www.theheart.org/web_slides/1425587.do
A randomized to placebo or ivabradine study on Systolic Heart Failure Treatment with the If Inhibitor Ivabradine (SHIFT) with patients on standard HF medications according to guidelines
How to manage delays in stroke treatment Jacek StaszewskiJacek Staszewski
This document discusses strategies to manage delays in stroke treatment. It notes that while thrombolysis and thrombectomy have improved outcomes, time is still critical factor. Various factors can contribute to delays including pre-hospital times, hospital workflows, and patient factors. Studies demonstrate improved outcomes with shorter onset-to-treatment and door-to-needle times. Initiatives like pre-notification, standardized protocols, telemedicine, and programs like Target: Stroke that focus on key strategies have been shown to reduce times and increase treatment rates. While challenges remain, an emphasis on collaboration, continuous quality improvement and learning from initiatives can help further reduce delays to improve patient outcomes.
This document summarizes a quality improvement project to implement a screening tool to improve thrombolytic therapy treatment for acute ischemic stroke patients. The project aimed to (1) improve door-to-needle times from 144 minutes to less than 80 minutes, (2) increase thrombolytic treatment rates from less than 5% to over 7%, (3) meet treatment guidelines for eligible patients over 85% of the time, and (4) have providers initiate the screening tool for 25% of eligible patients. The National Institute of Neurological Disorders and Stroke screening tool would be integrated into the emergency department's initial evaluation and treatment process over a 3-month pilot period.
This study analyzed data from over 31,000 orthopedic trauma surgery cases to determine if the time of day of surgery affected mortality and complication rates. The results showed that surgeries performed in the afternoon or at night had significantly higher mortality rates (1.1% in morning vs 2.4% at night) and general complication rates compared to morning surgeries. Higher rates of emergencies, injury severity, and surgeon fatigue after-hours may contribute to these outcomes. While no differences were found for intra- or post-operative complication rates based on surgery time, optimizing patient safety at all times, including surgeon self-awareness, is important.
Sophisticated Prehospital Stroke Systems of CarePSOW
1. Kerry Ahrens discusses the importance of building a stroke system of care in Wisconsin to improve patient outcomes through faster treatment times.
2. Stroke is a leading cause of disability and costs $34 billion annually in the US. Building regional stroke systems can help optimize patient care through protocols to administer tPA within 30 minutes and transfer patients with large vessel occlusions to interventional centers within 90 minutes.
3. Effective collaboration between EMS, hospitals, and healthcare agencies is essential to establish standardized processes and monitor performance metrics to continually improve the efficiency of stroke care delivery.
Organisation of stroke care - polish experience Jacek StaszewskiJacek Staszewski
The document describes the organization of stroke care in Poland, including the establishment of over 170 stroke units since 1997 that provide rapid assessment, treatment and rehabilitation for stroke patients. It outlines Poland's efforts to improve stroke management through increased utilization of thrombolysis, endovascular procedures, and adherence to clinical guidelines. Overall, Poland has made significant progress in developing its stroke care system but still aims to increase thrombolysis rates and availability of comprehensive stroke centers nationwide.
This document presents a literature review and proposal for a study to evaluate the effectiveness of home telemonitoring using an ECG monitor in reducing hospital readmission rates among patients aged 65 and older with heart failure. Heart failure results in many hospitalizations and readmissions that cost the healthcare system billions each year. The literature suggests that telemonitoring allows for early detection of exacerbations and improved management of heart failure symptoms, leading to fewer hospitalizations. The proposed study would compare readmission rates over 4 months for heart failure patients who use home ECG telemonitoring versus the standard telemonitoring system, with the hypothesis that ECG telemonitoring would reduce readmission rates.
Implementing American Heart Association Practice Standards for Inpatient ECG ...Allina Health
Implementing American Heart Association Practice Standards for Inpatient ECG Monitoring: An Interventional Study at Abbott Northwestern Hospital presented by Kristin Sandau, PhD, RN
The document discusses the value of information in healthcare and analyzing temporal patterns in patient care and health services. It provides examples of studies that analyzed patterns in test follow-up rates and mortality rates for weekend hospital admissions. While the studies found issues like high rates of unreviewed tests and higher mortality for weekend admissions, further analysis of temporal patterns provided insights into potential causative factors and opportunities for intervention. The value of information is realized when it leads to changes in decisions and care processes that improve outcomes.
Classification and Regression Tree Analysis in Biomedical Research Salford Systems
This document discusses using classification and regression tree (CART) analysis to develop clinical decision rules for three clinical settings: 1) emergency department triage of HIV-infected patients, 2) survival prediction of patients with colon and rectal cancer, and 3) prediction of neurologic survival in patients following out-of-hospital cardiac arrest. For each setting, the document describes developing CART models using various clinical variables to classify patients into risk groups and reports validation results for predicting outcomes like medical urgency and survival.
Quality measurement in cardiac surgery aims to improve outcomes by systematically tracking morbidity and mortality rates. Initially, unadjusted outcomes did not account for patient risk factors. This led to the development of risk-adjustment models like the Aristotle score and RACHS-1 score to stratify complexity and risk. The STS National Database was also created to provide standardized, risk-adjusted data from a large benchmark population. Effective quality measurement considers risk factors, standardized data, and outcomes beyond just mortality rates. Ongoing enhancements continue to advance cardiac surgery quality.
This document discusses common challenges in healthcare including clinical, financial, and managerial issues. Clinically, there are increased patient acuity, age and deterioration without adequate monitoring leading to issues like pressure ulcers and falls. Financially, there are concerns around increased ICU length of stay, overuse of telemetry and ICU beds, and reimbursement cuts for adverse events and readmissions. Managerially there are issues with staff accountability, inadequate management tools, alarm fatigue, and readmission prevention. The document advocates for first improving efficiency, effective care, safety, coordinated care, and reducing cost-related problems.
This document outlines a proposal to implement a rapid response team (RRT) at an urban Magnet hospital to improve patient outcomes on medical and surgical units. The purpose is to determine if an RRT can reduce hospital stays, decrease transfers to higher levels of care, and increase patient functionality at discharge. The proposal describes the background on RRTs, significance to nursing practice, literature review on clinical outcomes, relevant nursing theories, and the Iowa Model framework. It provides details on the methodology, team development and training, communication systems, education, documentation, and implementation process including activation protocols and safety huddles. The goal is to activate the RRT for at-risk patients showing signs of respiratory distress, changes in mental status, abnormal
Objective
Safer Healthcare Now!, a program of the Canadian Patient Safety Institute, invites you to participate in the Canadian VTE Audit, designed to establish a national perspective of VTE thromboprophylaxis rates and raise awareness of appropriate VTE prophylaxis.
VTE is one of the most common and preventable complications of hospitalization and is a Required Organizational Practice (ROP) of Accreditation Canada.
By participating in the national audit day you will be a part of a movement aimed at preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) in hospital patients.
Watch the recording: http://bit.ly/1wfinCE
This document discusses technology assessment, outcomes research, and economic analyses in healthcare. It provides background on rising healthcare costs in the US without clear improvements in health outcomes compared to other countries. The rationale for assessing new technologies and their impact is described. Key aspects of technology assessment are outlined, including technical efficacy, diagnostic accuracy, diagnostic impact, therapeutic impact, patient outcomes, and societal outcomes. Challenges with randomized controlled trials in assessing technologies are reviewed. The National Lung Screening Trial is presented as an example. Finally, computed tomography for appendicitis is analyzed as a hypothetical example of how modeling could be used to assess a technology when a randomized trial may not be feasible.
This presentation explains the concept of patient safety, healthcare quality and how these can be embedded into surgical care to ensure excellent patient outcomes.
These slides were presented to the Surgery Interest Group of Africa (SIGAF) in April 2023 by Vivian Akwuaka.
Similar to Stroke unit development and evaluation Jacek Staszewski 2015 (20)
Prevention of recurrent stroke in atrial fibrillation Jacek StaszewskiJacek Staszewski
Prevention of recurrent stroke in atrial fibrillation. Comaprison of NOAC vs VKA. Riks of hemorrhagic stroke. When anticoagulation should be initiated following acute stroke.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
3. Benefits of stroke unit (SU) care
1. Stroke Unit Trialists’ Collaboration. Cochrane Library 2013, 2. Seenan EXC, et al. Stroke 2007;38, Tamm CLO, et al. Stroke 2014;45:211-216; 4. Schouten
LM, et al. Stroke 2008;39:2515-2521; 5. Lannon R, et al. Ir J Med Sci 2011 Mar;180:37-40. 6. Ingeman A, et al. Stroke 2011;42:3214-3218.
Mortality1,2
Dependency1,2
Complications6
Independence2
Discharge
Home2,3
Length of stay1,4,5
Cumulative
indirect costs $
18.3 billion *
Cumulative
direct costs $
13.8 billion *
* estimated benefits of optimal stroke care in Canada: costs avoided 2010-2031
All patients regardless of age, sex, type of stroke, time of presentation benefit from stroke care.
4. % patients
that can
benefit
ARR (%)
death/
dependency
No. of dead and dependent
survivors avoided per yr/1 million
Stroke Unit 100% 5 69
Thrombolysis
0-4.5 hr
25%
ischaemic
strokes
6 12
Aspirin
0-48hr
80%
strokes
1 23
Hemicraniectomy
0-48hr
2%
ischaemic
strokes
16 7
All stroke patients should be treated in a stroke unit
Helsingborg Declaration 2006
ESO 2013 (Class I, Level A)
Hankey IMP. J R Coll Physicians Edinb 2010; 40; Gilligan EFF. Cerebrovasc Dis. 2005;20
To recover the patient must survive stroke complications
ARR – absolute risk reduction
5. Stroke Unit
A specified area in a hospital, staffed by a
dedicated, multidisciplinary team with
specialist knowledge and skill in stroke care.
SU is a fundamental element of stroke care
Stroke
unit
Ringelstein EB, et al. Stroke 2013;44
Stroke
rehabilitation units
Admit patients after a
delay of 1-2 weeks,
continue treatment and
rehabilitation for several
weeks
Acute SUs
Admit acute stroke
patients and continue
treatment for several
days (≈ less than 1week)
Integrated acute
and rehabilitation SU
Admit acute patients and continue
treatment and rehabilitation for
several weeks / months
• acute –care-driven (GB)
• intensive-care-like approach (DE)
• rehabilitation driven approach (SCN)
6. Risk reduction in death or dependency: SU vs GMW
GMW – general medical ward
Candelise SU. Lancet 2007;369
13% RRR
7. connection with EMS
transfer to the nearest SU
quick CT/blood tests for urgent patients
direct admission from ED
multiprofessional team approach
staff trained in delivering rt-PA
careful nursing care: swallow screening
cont. monitoring (ECG,BP), access to img.
prevention, treatment of complications
early mobilization /rehabilitation thx
secondary prevention
Coordination , Cooperation, Communication
written institutional stroke protocols*
Stroke treatment: process flow
SSNAP&ESO*criteriaforthequalityof
acuteSUorganisation
SSNAP – Sentinel Stroke National Audit Programme, Dec 2014
Ringelstein EB, et al. Stroke 2013;44
8. Hyperacute stroke service
Response times
Ringelstein EB, et al. Stroke 2013;44
Door-to-neurologist 30 minutes
Lab results
in rtPA candidates
Door-to-CT * 30 minutes
Door-to-Needle*
(80% threshold)
20 minutes
asap ≤ 60 minutes
* compulsory QI (ESO 2013)
Performance metrics apply to all patients not only to rtPA candidates !
9. Stroke Unit Trialists' Collaboration 2007; Ringelstein EB, et al. Stroke 2013;44:
SSNAP – Sentinel Stroke National Audit Programme, Dec 2014
General SU organisation
Key features
I. Consultant physician with responsibility for stroke
• 7 day consultant ward rounds
II. Weekly multidisciplinary meetings to plan/discuss pt care*
• clinical psychology
• palliative care treatment decisions
III. Formal links with patient/carer organisations
IV.Provision of information to patients about stroke
• involvement in discharge planning
• access to stroke-specific Early Supported Discharge team
V. Continuing education (annual teaching course) for medical
and nonmedical staff*
SSNAP&ESO*criteriaforthequalityofstrokecare
10. ESO stroke units
Hess DC et al. The history and future of telestroke. Nat. Ens. Neurol. 2013; Ringelstein EB, et al. Stroke 2013;44:828-840.
Tiered system of stroke care
Acute stroke patients should have access to high technology medical and surgical stroke care
AHA/ASA 2013; Class III, Level B
Development of clinical networks, including telemedicine, is recommended
Class II, Level B
•Part A : acute SU
≥ 4 beds
24h continous monitoring for ≥72hrs
1 monitored bed per 100 pts/yr
≥ 200 stroke or TIA patients /yr
≥ 16 rtPA pts/yr
•Part B : postacute step-down SU
2x the number of beds in part A
Drip
and
ship
Spoke
to
hub
ESO stroke centres
• more advanced equipment
• higher expertised staffing
• neuro-, vascular-surgery, interv.card.
• diversified and larger resources
• multiprofessional ICU, in-house ED
• hyperacute interventions
• on-site hemicraniectomy, thrombectomy
• stroke research
11. • to ensure EB requirements, standards are met
• done by an outside, independent experts
– Self-certification is not acceptable
– Process is elaborated by ESO Stroke Unit Certification Committee
• should include a site visit
• assessment of facilities, personnel, level of care,outcomes
• evaluation of stroke care pathway QIs
Certification process and quality assessment
QI - quality indicator
Certification of stroke centers by an independent external body is recommended
AHA/ASA 2013 Class I, Level B
Hospitals should organise a multidisciplinary quality improvement committee to monitor QIs
Class I, Level B
AHA/ASA Guidelines. Jauch et al. Stroke 2013, 24; Ringelstein EB, et al. Stroke 2013;44
12. Compulsory QIs based on best practices
ESO recommendation on quality measures
Ringelstein EB, et al. Stroke 2013;44; Detre EM, et al. NEJM 2013, 46
1. % acute stroke patients treated with i.v. rtPA having a DTN time <60 min
2. % acute patients with stroke treated on the stroke unit
3. % brain imaging by CT or MRI in every suspected stroke
4. % ischaemic stroke pts with antithrombotic therapy at discharge
5. Corresponding anticoagulation at discharge in patients with atrial fibrillation
6. % stroke unit patients screened for swallowing disorders
1. Vascular imaging in patients with ischaemic stroke or TIA
2. Brain imaging ≤1 hr of admission in pts arriving within 2 hrs after onset
3. % eligible patients receiving i.v. rtPA therapy
4. Carotid revascularisation for ≥50% symptomatic carotid stenosis
5. Statin treatment at the end of hospital stay in atherothrombotic strokes
6. Antihypertensive treatment at the end of hospital stay for hypertensive pts
7. Pre-hospital training program for laypersons and medical personnel
Every ESO Stroke Unit / Centre should at least work on 3 of the following 7
additional QIs
A local register and transfer of QIs (+stroke severity, age, sex for benchmarking) into
regional/ national databases is recommended
ESO 2013
QI - quality indicator
13. • Thrombolysis is underused
• 20–40% of EU hospitals treating stroke
pts do not perform rt-PA!
• Wide variability of national DTN times
– 15-35 min FI, 20-60 min UK, 15-170 min FR
– variations in a quality of care in existing SUs
• The majority of pts who receive rt-PA
have a DTN time ≥60 min
Is current EU stroke care effective enough ?
Budincevic H et al. Int J Stroke. 2015,10; Schwamm LH et al. Circulation 2013; 6
Scholten et al. Implement Sci 2015; Ferrari J et al. J Neurol 2013; Tai YJ et al. Int Med J 2013
11.8%
8.9% 7% 7%
18.3%
rt-PA rates
39%
EU
14. Chain of survival
Stroke is an emergency
Jauch et al. Stroke 2013; AHA/ASA Circulation 2005; Deng et al. Neurology 2006
• Public campaigns (knowledge of stroke symptoms & avoid delayed seeking medical attention)
• Centralised emergency number (triage prior to dispatch of emergency team)
• Standardised protocols & instruments for early stroke recognition (e.g. FAST, LAPSS)
• Emergency and direct transfer to hospitals with stroke / endovascular expertise
AHA/ASA 2013 Class I; Level of Evidence B
Quick recognition
Reaction to stroke signs
Rapid dispatch Priority transport ER triage Rapid in-hospital
diagnosis and
treatment
Patient EMS Transport CT/MRI Treatment
50–80% of delays
Collaboration between pre- and in-hospital stroke care providers!
15. Pre-hospital notification
Code Stroke
• Mobilisation of appropriate hospital
resources
• Bypassing administrative admission
• Activation of Code Stroke
– decreases time to stroke team arrival & CT
scan interpretation
• Shortens door-to-needle time
– 41 min vs. 57 min (Lille, FR)
• Increases likelihood of rt-PA treatment
– 22% vs. 5%
Abdulah AR et al. Prehosp Emerg Care 2008; Casolla B et al. J Neurol 2012; Patel MD et al. Stroke 2011
16. Advanced pre-hospital stroke management
• Telemedicine
– supply 24/7 access to specialist stroke
expertise
– patient relevant data to the receiving site
• Pre-hospital thrombolysis
– call–to-needle time: 51 vs. 76 min
in routine care
– OTT ≤ 90 min: 58% vs. 37%
– rt-PA rates: 33% vs. 21%
– no difference in ICH, mortality rates
– can be integrated into the service chain
Ebinger PL et al. JAMA 2014; Weber ST et al. Neurology 2013
17. Single interventions to reduce rt-PA delays
Eissa A et al. J Clin Pharm Ther 2012; Tai YJ et al. Int Med J 2013
% rt-PA
2% 11%
Only the assessment of blood glucose must precede the initiation of intravenous rtPA
AHA/ASA 2013 Class I; Level of Evidence B
18. Strategies of in-hospital acute stroke management
Tai YJ et al. Int Med J 2013; Fonarow GC et al. Circulation 2011
Streamlined (Helsinki model)
Stroke
physician
ED
physician
Emergency department
Stroke team
CT
scanner
DTN (median): 20 min vs. 105 min
DTN ≤ 60 min: 94%
Triage
POC tests
iv rt-PA
Parallelprocessing
Pre-notification
History taking
Pre-registration
“Do as little as possible
after the patient has arrived
at the ER and as much as
possible before the patient
is being transported”
Meretoja A et al.
CT/testsrequests
19. Get with the Guidelines Target:
Stroke
• A national quality improvement initiative from the AHA/ASA
• Aim: to ensure that as many patients as possible with AIS
achieve a DTN time ≤60 min
• 10 key best practice strategies, associated with faster DTN
AIS = acute ischaemic stroke; DTN = door-to-needle; EMS = emergency medical service;
POC = point-of-care; rt-PA = recombinant tissue plasminogen activator
Fonarow GC et al. Stroke 2011;42:2983-9
1. EMS pre-notification
2. Rapid triage protocol and stroke
team notification
3. Single call to active stroke team
4. Stroke tools
5. Rapid imaging and interpretation
6. Rapid laboratory testing and
POC test
7. Premixing rt-PA
8. Rapid access to rt-PA
9. Team-based approach
10. Rapid data feedback
20. Before and after “Target: Stroke”
DTN times ≤ 60 min
AIS = acute ischaemic stroke; DTN = door-to-needle; rt-PA = recombinant tissue plasminogen activator
Fonarow GC et al. JAMA 2014
Pre- Post-intervention
Median DTN (min) 77 67
53.3%
29.6%
21. Before and after “Target: Stroke”
Clinical outcomes
Outcome* Before
Target: Stroke
(n=27,319)
After
Target: Stroke
(n=43,850)
Difference
(before/after)
P Value
In-hospital
mortality
9.93% 8.25% -1.68% <0.0001
Discharge
home
37.6% 42.7% +5.1% <0.0001
Ambulatory
status
independent
42.2% 45.4% +3.2% <0.0001
Symptomatic
ICH
5.68% 4.68% -1.00% <0.0001
Any rt-PA
complications
6.68% 5.50% -1.18% <0.0001
* Significant after adjustment for potential confounders (age, baseline stroke severity, hospital characteristics)
International Stroke Conference 2014
AIS = acute ischaemic stroke; DTN = door-to-needle; rt-PA = recombinant tissue plasminogen activator
Fonarow GC et al. JAMA 2014
22. The QUICK Stroke Initiative
Making Every Second Count Towards Stroke Recovery
Objective of the QUICK Stroke Project:
Reduce the delays in the stroke management
process of participating hospitals
By measuring the delays in the stroke management
Pre-hospital phase
Hospitalization phase
Specialized care phase
By identifying the points of improvement in each step
By implementing a specific action plan
By preparation of the comparative analysis
1
Y
E
A
R
1st snapshot
2nd snapshot
www.quick-initiative.com
23. The QUICK initiative in Poland
Main actions taken
Actions aiming at improving the hospital delays and the alert phase:
• Procedures
– implementation/re-evaluation of stroke alert procedure (in 10 hospitals)
– new patient card to fill in ambulance during transport (2)
• Training
– neurology personnel (10) & ER staff, lab/CT technicians training (4)
– training for ambulance service – “Load and go strategy” (2)
• Communication
– regular “stroke team” (10) & ER, CT, Lab meetings (3)
– display of the stroke alert procedure in the ER (4)
– site visits of centres by stroke experts for good practice sharing (2)
– local patient awareness campaign (5)
10/25 selected hospitals finished the study
510 patients were recruited (2012-2013)
24. Main delays:
Overall delay to medical decision
0
50
100
150
200
250
300
350
400
450
500
First symptoms to medical
decision
Median:
- 50 min
Med=225 Med=175
Snapshot 1
Sep 2012
Snapshot 2
Apr 2013
50-min reduction (22%)
Alert phase: Onset of symptoms - to arrival at hospital
• median ↓ 40 min (137 vs. 97 min)
First symptoms to call to ambulance: ↓ 36 min (60 vs. 24 min)
Call to ambulance to arrival at hospital: ↓ 8 min (50 vs. 42 min)
Hospital phase: Arrival at the hospital - to medical decision
• median ↓ 11 min (71 vs. 60 min)
Arrival to laboratory results: ↓ 13 min (82 vs. 69 min)
Arrival to consultation with neurologist : ↓ 2 min (7 vs. 5 min)
Door-to-CT: 30 min
25. Main delays
Hospital phase
9-min reduction (11%)
Med=89 Med=80
Snapshot 1 Snapshot 2
Median:
-9 min
rt-PA rate (2012 vs 2013)
12.6% 16.6%
7/10 sites improved rates
Door to medical decision ≤60 min: 31% vs 50%
26. New strategies to improve stroke management:
ESO-EAST
• ESO initiative to support Eastern European
countries to optimise & implement best stroke
care practice locally
• AIM: to improve stroke treatment, research and education
– developing a strategy to optimize and implement best practices
– annual workshops over 5 years from 2015
– leading stroke specialists from 15 countries
– facilitate interactions with government agencies, collaboration
– unrestricted grants from industry (EVER, Boehringer Ingelheim)
– leadership: V. Caso, R. Mikulik + ESO Board members
27. The angels initiative is a project
sponsored by BI, aimed at optimising
and setting up acute stroke networks in
low- and middle-income countries with the
support of local and international
stroke societies.
The angels initiative is only available in Africa, Brazil, China, Eastern Europe, India, Mexico, Middle East and South East Asia.
28. The angels initiative “start-up kit” for registered hospitals will contain…
Checklists
and scoring
tools
Standard
forms &
protocols
Stroke
treatment
process flow
Slide kits &
training sets
Expert help
Body Interact
simulations
QUICK
initiative
quality
control
FAQ & tips
and tricks
International
guidelines
Motivational
materials
The angels initiative is only available in Africa, Brazil, China, Eastern Europe, India, Mexico, Middle East and South East Asia.
http://www.angels-initiative.com/
29. Main goal:
Perfect organisation of hyper/post-acute stroke service
• Develop full emergency chain
• Identify and track delays
• Take effort to shorten time to treatment
• The biggest gains and losses occur in the hyperacute phase
• Decrease variation in pts management by use of internal protocols
• Audit and feedback to improve organized stroke care
• Expand the local stroke network to improve access to stroke service
• Learn by doing & Share experience
Medicine has made a substantial progress in the past few years and at last stroke has become a treatable disease.
The discussion about present stroke therapies should never omit what has been the main achievement in stroke treatment within last decades.
Definitely it’s been the developement of specialised SUs.
My task is to address a question how can we do better in terms of in-hospital management of hyper acute ischemic strokeBut first of all I’d like to thank the organisers for inviting me here and having a chance of sharing our experience on this topic and on this forum.
9:45-10:05 Tackling stroke in a developing country - CEE perspective Alexander Tsiskaridze
10:05-10:25 Stroke research activity – CEE perspective Robert Mikulik
10:25-10:45 Stroke unit development and evaluation – what we can improve? Jacek Staszewski
10:45-11:05 ESO EAST Initiative “Enhancing and Accelerating Stroke Treatment” Nikolay Shamalov
11:05-11:25 Challenges in stroke care organization -Ukraine perspective Jurij Flomin
Organisation of stroke services varies across different countries due to variations in healthcare systems, financing, facilities and involvement of the government.
We are concerned about new therapies and new treatment modalaities and sometimes we should not forget what
Organisation of stroke services varies across different countries due to variations in healthcare systems, financing, facilities and involvement of the government.
the introduction of the stroke tretment based o
In majority of WE and CEE countries SU and modern stroke management are on a high level – and we can ask a question Is there antything we can improve ?
In majority of WE and CEE countries SU and modern stroke management are on a high level – and we can ask a question Is there antything we can improve ?
In Central and Eastern European countries, 60–70% of hospital beds are taken up by stroke patients in the majority of neurology departments. In the past few years, the diagnostic workup and management of stroke (lysis, mechanical thrombectomy etc.) have undergone revolutionary changes. Guideline recommendations cannot always be applied in real-life situations. The difference between a stroke specialist and a neurologist is that a stroke specialist has the kind of experience that allows for adequate therapeutic and diagnostic decision-making in situations that are not clearly covered by guidelines (some examples include acute stroke with acute or chronic coronary artery disease, multiplex vascular malformations, concomitant tumor, coagulation disorders etc.). Further advances could be achieved by equipping ambulances with CT scans, which would allow for the distinction between hemorrhagic and non-hemorrhagic strokes on the premises and prompt diagnosis, especially in polytrauma cases. Now that everyone has a mobil e phone, it would be nice to have an application that could send an alarm to a stroke center if the owner’s speech changes, e.g. becomes dysarthric. There should also be applications that would loudly remind patients to take their medications from time to time or call attention to missed doses. The operation of an acute stroke center is ideal if it has regular contact with previous stroke patients. Prescript_ions and regular check-ups should be performed by general physicians but patients should present at a stroke center at least every 6 months (especially patients with multiple comorbidities, and those with carotid artery stenosis). The stroke specialist of the stroke center should also monitor the quality of care provided by GPs. Transportation by helicopter and TeleStroke will become widespread in the following years, and comprehensive vascular intervention centers will be established that allow for the desobliteration of coronary and cerebral arteries and for intensive monitoring afterwards. I look forward to the development of thrombolytic agents that are more effective than t-PA. I expect a breakthrough in the field of hemorrhage, especially via the administration of tissue plasminogen activator or other thrombolytic agents into the hematoma. Public awareness is essential. You may have the best technology, the best physicians, the best prehospital management, but this will be completely unuseful if patients call 24 hours later. Guideline recommendations cannot always be applied in real-life situations. The difference between a stroke specialist and a neurologist is that a stroke specialist has the kind of experience that allows for adequate therapeutic and diagnostic decision-making in situations that are not clearly covered by guideline. Even in the United States, the rate of venous thrombolysis is under 10%. Although mechanical thrombectomy represents a significant progress in this field, the next breakthrough will be achieved when patients arriving beyond the time window (e.g. wake-up stroke) can be reliably classified based on the necessity for desobliteration.
Stroke unit care remains an excellent example of closing the evidence-to-care gap, with Level 1 evidence for the benefits.
It increases chances for independence, discharge home, reduces risk for mortality, dependency, complications and shortens lenght of stay in the hospital.
Importantly all groups of patients regardless of age, sex, type of stroke and also those presenting late benefit from organised stroke care.
These effects generate costs benefits in different models from different countries f.e. stroke care in Canada avoided more than 18 billion dollars indirect costs and 13 billion dollars direct costs within 20 years.
SU care is so effective, because to recover, the patient must survive the complications of stroke .
The effects of Sus improve outcomes of stroke to the level of thrombolysis, they apply universally, and have large population benefit.
Taken it together SU care is the gold standard in stroke care and this is widely supported concept that has been recommended since the first high level stroke statement – the Helsingborg Declaration in 2006 to most current stroke guidelines.
There is substantial evidence around what constitutes good IS care.
Helsongborg declaration which was the first (high level ?) statement of the overall aims and goals of five aspects of stroke management to achieve till 2015. It has been established since the 1990s that appropriate organization of care in stroke has the same role as introduction of new therapies in the acute phase of stroke.
Stroke unit is the fundamental, basic element of stroke care regardless of hospital level of reference.
Conceptually, this is clear that grouping patients in a specified area in the hospital and providing care by a multidisciplinary team of professionals results in better outcomes.
However there is no one general model of Stroke Unit care, as this reflects country specific approach.
Nowadays in Europe, there are tendencies to establish SUs that incorporate features of the British acute care driven, the German intensive care like and Scandinavian „stroke-rehabilitation units” approaches or to establish comprehensive/integrated acute and rehabilitation SUs that admit acute patients and continue treatment and rehabilitation for a longer time.
Effective stroke unit management must be organised˛and provided by coordinated team of profeesionals. : as it gives rise to effective stroke treatment in ordinary hospitals as well as in referral or academic centres and finally forms stroke unit networks.
The first stroke units in EU were established in Scandsinavian hospiotals in the 1980s followed by other countries.
Elements of are also considered important which emphasises the importance of multimodal monitoring, ultra early etiologiocal clarification and active medical treatment.
Organisation of stroke services varies across different countries due to variations in healthcare systems, financing, facilities and involvement of the government. . [A stroke unit is defined as a specified area or ward in a hospital, staffed by a dedicated multidisciplinary team with specialist knowledge and skill in stroke care.]
Integrated acute and rehabilitation (comprehensive) stroke unit
The effectiveness may differ with regard to costs in selected country etc. What kind of stroke unuits
Many studies confirmed the superiority of each of these approaches over general medical wards.
According to a metanalysis of data there was a significant 13% of relative risk reduction in death and dependency in persons admitted to a SU compared with those admitted to a general medical ward.
Stroke patients admitted directly to an acute stroke unit fare better than those admitted to a general medicine ward.
However as stroke treatment is a complex process to achieve all of the benefits from SU care the following features need to be delivered.
They comprise of:
strict connection with the EMS with prenotified transfer of the pt to the nearest SU
immediate access to CT/blood sampling at ED
multiprofessional team approach, staff trained in delivering rtPA, careful nursing care with swallow screening, continous monitoring, quick access to neuroimaging, early prevention and treatment of complications and mobilization
finally all of these actions should be coordinated and based on written institutional protocols that document responsiblities and time frames for each actions.
Majority of these features form criteria for the assessment of the quality of acute SU organisation which fe. are evaluated by Sentinel Stroke National Audit Programme in the UK and are also specified (listed) by current ESO recommendations.
Hyperacute stroke service should be well organised to meet the following response times which apply on 24/7 basis. They consist of: door-to-neurologist that need to be achieved within 30 min, lab results in candidates for the acute interventions to be obtained within 20 minutes, doortoCT within 30 min, and door-to-needle as soon as possible, preferably be maintained within 30 minutes, in majority of pts within 60 minutes.
These performance metrics : door to Ct, door to neurologist apply to all patients not only to rtPA candidates.
Door-to-ct and door-to-needle times are also recommended by ESO as compulsory quality indicators of the hyperacute stroke service.
These response times serve as a easy to record performance metrics in many stroke registries such as GWTG, SITS
They are similar but not identical for American and european recommendations and these discrepancies reflect difference in organisation models on national level.
From the wider perspective, general SU organization should be characterized by the 5 following key features, which are evidence based and were evaluated in the Stroke Unit Trialists' Collaboration study.
They consist of: wide availability of consultant physician with responsibility for stroke preferably 7 days a week
weekly multidisciplinary meetings involving clinical psychology and pallative care specialists to discuss treatment decissions
establishing formal links with patients or carer organisations
provision of information to patients about stroke, discharge planning and access to stroke specific early supported discharge team if available
and also providing continuing education for medical as well as nonmedical staff.
These key features do not require financial resource and should be considered as fundamental for all sus.
They also form criteria for the quality of stroke service assessed by Sentinel audit and required by the ESO.
On a higher, national level the effective system of stroke care is based on regional (spoke) hospitals cooperating with comprehensive, reference stroke centre (hub) located on the top of the system. They form care networks with hospitals without stroke expertise : widely make use of telemedicine and drip and ship strategies to streamline acute stroke care. Latest ESO guidelines have introduced new therminology replacing older ones and specified the criteria for: the ESO SU and ESO stroke centres. ESO SU should consist of 2 functional parts : part A refers to acute SU and should have at least 4 beds and provide continous monitoring for the avarege of 72 hrs. One monitored bed is recommended per 100 patients a year.
To ensure an acceptable level of expertise at least 200 stroke/TIA patients /yr should be admited , on average 16 pts per year’d be treated by iv rtPA.
The postacute step-down SU should include twice the number of monitored beds as part A.
For ESO stroke centres additional requirements are mandatory such as more advanced equipment, higher expertised staffing, 24/7 availability of neurovascular/vascular surgery services on site, diversified and larger resources enabling hyperacute interventions f.e. hemicranniectomy and thrombectomy oin site and stroke research.
To ensure EB requiremnents, high standards and quality are met, stroke units should be: firstly certified by an outside, independent experts and secondly: regularly assessed by internal quality improvement committee organised by each hospital.
Self-certification is not acceptable , currently the process of certification is being elaborated by the ESO stroke unit committee.
Certification process should include a site visit to make assessment of facilities, personnel, protocols, and outcomes measurred by QIs
These measures should also be monitored not only be external bodies but
and wether it will be performed by that body or national experts is a matter of debate.
The ESO proposes
that different types of quality indicators may apply in different countries,
ESO stroke units and c
Formal certification is important to ensure requirements, standards, and performance are met
entres and shouuld be certified!
Must include an assessment of facilities, personnel, protocols, and outcomes
Should include a site visit
Some information submitted on-line
Based on best practices, ESO endorsed (zatwierdzać) the 6 compulsory following quality measures : only 1 refers to rtPA pts, 1 refers to % of pts treated in the SU, the rest 4 refer to diagnostic procedures and prevention of stroke complications. Every SU should work on addidtional 3 of 7 Qis: referring to neuroimaging, % of pts receiving with tPA, carotid revascularisation, statin and antihypertensive tretament, and organisation of prehospital training program for laypersons. These data - as well as determinants of stroke outcome such as stroke severity, patients age, sex for benchmarking- should be transferred into local or national databases. However in many countries there is no consenus on how often, which variables and which platform to use to collect information – within ESO EAST group we are working on that. As prof. Mikulik said, probably platform created in SITS registry will be the most convinient for every day use.
Why should this be done? Is not current stroke care not effective enough ? We still have a lot to do.
According to the latest reports, in general only 39% stroke pts in Europe has admission to SU, it can be as high as in CZE >80%, >60% in PL, R, Estonia, Belarus, but can be lower than 50%. National registries are seldom conducted.
RtPA treatment is underused and IV TPA rate also varies and based on the latest reports it is within wide range f.e. between 7% of all stroke admissions in Pl, US and 18% in Austria. 20-40% of EU hospitals treating stroke pts do not perform tPA at all. There is still wide variability of national DTN time what reflects variations in quality of care in existing Sus.
So an ongoing effort should be made to overcome these delays as reducing the treatment times is the single most important modifiable factor to improve patient outcomes.
Beside a growing numer of experienced stroke networks, approximately 50% of stroke patients arrive to ER outside of tPA therapeutic time window and majority of those who receive tPA have DTN time that exceeds recommended golden hour.
So an ongoing effort should be made to first diagnose and then overcome these delays as reducing the treatment times is the single most important modifiable factor to improve patient outcomes.
Suppl A100:125-7. doi: 10.1111/ijs.12575. Epub 2015 Jul 14.
Management of ischemic stroke in Central and Eastern Europe.
Budincevic H et al. Int J Stroke. 2015 Oct;10
admission to hospitals with no organised stroke care
not evidence-based care
From the every-day perspective tPA is still underused as only minority of AIS pts receive this treatment because of many different delays.
Even within the hospital, time can be lost.
Beside a growing numer of experienced stroke centers, many tPA treated pts have still DTN time that exceeds the recommended golden hour.
So an ongoing effort should be made to overcome these delays as reducing the treatment times is the single most important modifiable factor to improve patient outcomes.
These are theoretical assumptions but are they met in a real life ?
Present situation. Why shall we discuss the development and function of SU ?
If the % of rtPA is a marker of SU effectiveness the quality is far from optimal with [] Stroke - the most common disease worldwide
incidence (M/F): 101–239 / 63–158 per 100,000
243,000 hospitalizations in Germany (2010)
92,500 in Poland (2013)
Incidence will double in the next 20 years
The effective management of acute stroke highly depends on cooperation between 5 pre-hospital and in-hospital links in the so called stroke chain of survival. All these links are equally important.
More than half of the delays are generated in prehospital phase.
To reduce them, many interventions have been recommended:
public awareness campaigns to raise knowledge of stroke symptoms, to avoid delays in seeking medical attention and to use centralized emergency number.
educational programmes for EMS personnel that promote „fast track for stroke” by using protocols for rapid dispatch and standardised instruments for diagnosis of stroke such as FAST scale which is easy and rieliable and can be used by either EMS or by community members.
Emergency priority transport - the same as that for acute myocardial infarction with direct transfer to hospitals with stroke expertise
But the most beneficial is continuous communication and collaboration between pre- and in-hospital stroke care providers based at the local level.
Even basic communication between EMS and stroke/ER physicians befor the patient arrives to the hospital is crucial.
Prenotification concept comes from battlefield from Vietnam war and was later succesfully adapted for other emergency services.
It enables mobilisation of hospital resources, bypassing administrative admission and early activation of stroke team.
These procedures decrease intra-hospital delays. F.e. in Lille in France, DTN time was reduced by 15 minutes and IV thrombolysis occurred 4 times more often in pts admitted after pre-hospital notification and code stroke activation.
Future directions in prehospital acute stroke management will possibly comprise of:
- telemedicine technologies which have great potential to supply immediate access to specialist stroke expertise and also can help to provide patient-relevant information to the receiving hospital.
- pre-hospital thrombolysis in the mobile stroke unit staffed by a neurologist and equipped with a mobile CT scanner and a point-of-care laboratory. So called Strokebus was evaluated here in Berlin and the pilot study showed encouraging results for both treatment safety and efficacy. Probably mobile stroke unit could be integrated into routine service chain in the future especially in rural locations.
But this is a future; coming back to Earth we should especialy be aware of hospital delays.
To overcome these delays many single interventions have been proposed. Each of them may be especially essential in local, specific settings. Generally the most important is appropriate stroke triage in Emergency Department that means giving the same high priority for stroke patient as for an hemodynamically unstable or trauma patient. This intervention has been shown to reduce delays by almost an hour and significantly increase tPA rates. It should be stressed that in typical tPA candidate only the assessment of blood glucose must precede the initiation of intravenous rtPA. In warfarin anticoagulated pt POC INR testing is very helpfull and this can save half an hour compared with awaiting for central lab results. Also advanced imaging should not delay the treatment
Any single intervention can result in optimal reductions in delays but they rather result from stepwise improvement of the system as a whole.
The most effective and impressive model is – Helsinki model – It is streamlined and based on: prenotifiaction with medical history taking, and preregistreation together with preparing CT and tests requests before the pts arrives to Emergency Room.
After arrival the pt is bypassing the ED and taken directly to the ct scanner on ambulance stretcher where he is parallely processed : he is being examined, has point of care INR test and finally receives treatment before the admission to stroke unit.
This model was shown to reduce DTN down to amazing 20 minutes in Helsinki in majority of pts and what is important it did not result in any increase of misdiagnoses. The authors stress that to obtain maximal reductions of delay majority of actions should be done before the pt arrives to ED.
To improve standards of hyperacute stroke care on larger scale, on national level: a Get with the guidelines target stroke initiative was launched over ten years ago in US. More that 1500 hospitals have participated and achieved improvements by implementing 10 preselected best practice strategies associated with faster DTN that we have already discussed.
Basing on these actions: DTN time for tPA administration improved significantly from median of 77 minutes in the preintervention period to 67 minutes during the postintervention period.
% of pts that received tPA<60 min increased from 29% to 53% within just 4 years.
These gains resulted in lower in-hospital mortality and intracranial hemorrhage, along with an increase in patients independence and the percentage of patients discharged home.
These findings remained highly statistcally significant after adjusting for patient and hospital characteristics.
To improve management of hyperacute stroke in other countries, the quick stroke initiative project has been launched in 100 centres in Poland and other 12 mainly European countries.
Quick was aimed to reduce delays in participating hospitals by first of all :
measuring delays in prehospital, ED, specialized care phase in the first snapshot , then identifing the points of improvement , implementing a specific action plan and finally by preparation the comparative analysis in the 2nd snapshot.
I am going to present the results from 10 Polish sites with primary or comprehensive stroke units which represent conventional model of stroke management in Poland. 510 pts – appx 50 per site were screened in 2 snapschots
3 main actions aiming at improving the hospital delays and the alert phase have been taken.
They consisted of : reevaluation and implementation of stroke alert procedures, comprehensive training for neurologist, ER staff, paramedics and ambulance service with promotion of „load and go strategy, improving communication by setting up regular stroke team and ER staff meetings, and also setting up local patient awareness campaignes
The QUICK initiative in Poland gave positive results:
Within just a few months – thanks to the monitoring and action plan- the median dalay from first symptoms to medical decision decreased by 50 min.
It was achiewed by significant decrease of predominantly alert phase –by 40 minutes and resulted from reductions of the hospital phase by 11 minutes due to primarly more effective blood samples management.
The door to needle improved by 9 minutes from 89 minutes to 80 minutes and it still leaves a room for improvement, but door to medical decision increased significantly from 31 to 50%, 7 of 10 sites improved tPA rates from 12.6% to 16.6% based on this small could we say achievement.